The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
3
- 1
Alavijeh, Mohammad Sadeghi, Professor
Born in December 1961Individual (5 offsprings)Officer2002-05-17 ~ nowOF - Director → CIF 0Alavijeh, Mohammad Sadeghi, Professor
Individual (5 offsprings)Officer2002-05-17 ~ nowOF - Secretary → CIF 0 - 2PHARMIDEX HOLDINGS LIMITED - nowSHELLCO 128 LIMITED - 2011-12-16167-169, Great Portland Street, Fifth Floor, London, United KingdomActive Corporate (1 parent, 2 offsprings)Net Assets/Liabilities (Company account)503,161 GBP2024-12-31Person with significant control2016-04-06 ~ nowPE - Ownership of shares – 75% or more → CIF 0
- 3A2E PARTNERS LIMITED - 2000-10-1057, Princess Street, Manchester, United KingdomActive Corporate (3 parents, 37 offsprings)Equity (Company account)2 GBP2024-12-31Officer2011-03-11 ~ nowOF - Director → CIF 0
Ceased
5
- 1
Palmer, Alan Michael, Prof
Co Founder And Chairman born in January 1958Individual (4 offsprings)Officer2002-05-17 ~ 2008-06-17OF - Director → CIF 0 - 2
Amiri, Said Amin
Financier born in September 1956Individual (69 offsprings)Officer2009-07-07 ~ 2011-03-11OF - Director → CIF 0 - 3
Poormand, Ghassem, Dr
Company Director born in October 1950Individual (2 offsprings)Officer2008-03-26 ~ 2025-08-05OF - Director → CIF 0 - 4INTERLINK TRADE LIMITED - now
INCORPORATE DIRECTORS LIMITED
- 2015-04-30Mellier House, 26a Albemarle Street, LondonDissolved Corporate (1 parent, 2 offsprings)Equity (Company account)1 GBP2022-12-31Officer2002-05-17 ~ 2002-05-17PE - Nominee Director → CIF 0 - 5Mellier House, 26a Albemarle Street, LondonActive Corporate (1 parent, 212 offsprings)Equity (Company account)1 GBP2024-12-31Officer2002-05-17 ~ 2002-05-17PE - Nominee Secretary → CIF 0
Company in focus
PHARMIDEX PHARMACEUTICAL SERVICES LIMITED
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
512,666 GBP2024-06-30
545,944 GBP2023-12-31
Property, Plant & Equipment
1,797,988 GBP2024-06-30
1,833,474 GBP2023-12-31
Fixed Assets
2,310,654 GBP2024-06-30
2,379,418 GBP2023-12-31
Total Inventories
766,306 GBP2024-06-30
544,172 GBP2023-12-31
Debtors
688,261 GBP2024-06-30
861,238 GBP2023-12-31
Cash at bank and in hand
90,681 GBP2024-06-30
81,798 GBP2023-12-31
Current Assets
1,545,248 GBP2024-06-30
1,487,208 GBP2023-12-31
Creditors
-2,078,395 GBP2024-06-30
-1,855,202 GBP2023-12-31
Net Current Assets/Liabilities
-533,147 GBP2024-06-30
-367,994 GBP2023-12-31
Total Assets Less Current Liabilities
1,777,507 GBP2024-06-30
2,011,424 GBP2023-12-31
Net Assets/Liabilities
989,442 GBP2024-06-30
1,149,325 GBP2023-12-31
Equity
Called up share capital
136,299 GBP2024-06-30
136,299 GBP2023-12-31
Share premium
1,966,497 GBP2024-06-30
1,924,897 GBP2023-12-31
Revaluation reserve
604,425 GBP2024-06-30
604,425 GBP2023-12-31
Retained earnings (accumulated losses)
-1,717,779 GBP2024-06-30
-1,516,296 GBP2023-12-31
Average Number of Employees
372024-01-01 ~ 2024-06-30
392023-07-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Development expenditure
665,565 GBP2024-06-30
665,565 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
152,899 GBP2024-06-30
119,621 GBP2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Development expenditure
33,278 GBP2024-01-01 ~ 2024-06-30
Intangible Assets
Development expenditure
512,666 GBP2024-06-30
545,944 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Land and buildings, Under hire purchased contracts or finance leases
47,992 GBP2023-12-31
Plant and equipment
2,440,188 GBP2024-06-30
2,392,570 GBP2023-12-31
Furniture and fittings
198,592 GBP2024-06-30
197,851 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
2,686,772 GBP2024-06-30
2,638,413 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Under hire purchased contracts or finance leases
7,199 GBP2023-12-31
Plant and equipment
719,397 GBP2024-06-30
643,460 GBP2023-12-31
Furniture and fittings
159,789 GBP2024-06-30
154,280 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
888,784 GBP2024-06-30
804,939 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings, Under hire purchased contracts or finance leases
2,399 GBP2024-01-01 ~ 2024-06-30
Plant and equipment
75,937 GBP2024-01-01 ~ 2024-06-30
Furniture and fittings
5,509 GBP2024-01-01 ~ 2024-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
83,845 GBP2024-01-01 ~ 2024-06-30
Property, Plant & Equipment
Plant and equipment
1,720,791 GBP2024-06-30
1,749,110 GBP2023-12-31
Furniture and fittings
38,803 GBP2024-06-30
43,571 GBP2023-12-31
Land and buildings, Under hire purchased contracts or finance leases
40,793 GBP2023-12-31
Raw Materials
125,540 GBP2024-06-30
116,262 GBP2023-12-31
Value of work in progress
640,766 GBP2024-06-30
427,910 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
292,998 GBP2024-06-30
490,446 GBP2023-12-31
Prepayments/Accrued Income
Current
146,212 GBP2024-06-30
143,327 GBP2023-12-31
Other Debtors
Current
35,172 GBP2024-06-30
42,156 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
213,879 GBP2024-06-30
185,309 GBP2023-12-31
Finance Lease Liabilities - Total Present Value
Current
235,681 GBP2024-06-30
209,380 GBP2023-12-31
Trade Creditors/Trade Payables
Current
933,590 GBP2024-06-30
793,782 GBP2023-12-31
Bank Borrowings/Overdrafts
Current
10,027 GBP2024-06-30
10,027 GBP2023-12-31
Other Taxation & Social Security Payable
Current
143,152 GBP2024-06-30
131,923 GBP2023-12-31
Other Creditors
Current
170,167 GBP2024-06-30
208,338 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
435,968 GBP2024-06-30
345,332 GBP2023-12-31
Creditors
Current
2,078,395 GBP2024-06-30
1,855,202 GBP2023-12-31
Finance Lease Liabilities - Total Present Value
Non-current
349,374 GBP2024-06-30
413,380 GBP2023-12-31
Bank Borrowings/Overdrafts
Non-current
14,167 GBP2024-06-30
19,167 GBP2023-12-31
Minimum gross finance lease payments owing
Amounts falling due within one year
235,681 GBP2024-06-30
209,380 GBP2023-12-31
Between one and five year
349,374 GBP2024-06-30
413,380 GBP2023-12-31
Minimum gross finance lease payments owing
585,055 GBP2024-06-30
622,760 GBP2023-12-31
Finance Lease Liabilities - Total Present Value
585,055 GBP2024-06-30
622,760 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
19,611 shares2024-06-30
Nominal value of allotted share capital
Class 1 ordinary share
1 GBP2024-01-01 ~ 2024-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
480,768 GBP2024-06-30
480,768 GBP2023-12-31
Between one and five year
1,918,512 GBP2024-06-30
1,918,512 GBP2023-12-31
More than five year
940,609 GBP2024-06-30
1,180,423 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
3,339,889 GBP2024-06-30
3,579,703 GBP2023-12-31
- Registered number 04441512
PHARMIDEX PHARMACEUTICAL SERVICES LIMITED
Info167-169 Great Portland Street, Fifth Floor, London W1W 5PFPRIVATE LIMITED COMPANY incorporated on 2002-05-17 (23 years 9 months). The company status is Active.The last date of confirmation statement was made at 2025-05-17CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.